Literature DB >> 750147

Comparison of human myofibrillar protein catabolic rate derived from 3-methylhistidine excretion with synthetic rate from muscle biopsies during L-[alpha-15N]lysine infusion.

R O McKeran, D Halliday, P Purkiss.   

Abstract

1. Urine was collected in five healthy men over 10--14 days, with fasting blood samples on days 1, 5 and 10, whilst they consumed a standard creatine-free diet, which was quantitatively related to their body surface area. 2. The urinary excretion of 3-methylhistidine fell to a plateau by day 5 in all subjects. Myofibrillar protein catabolic rate calculated from the mean value of 3-methylhistidine excretion from day 5 to day 10 averaged 1.21 g day-1 kg-1 body weight. The average turnover of muscle myofibrillar protein was calculated to be 2.16%/day. 3. From a previous study using continuous intravenous infusion of L-[alpha-15N]lysine with serial muscle biopsies on the same subjects, the mean myofibrillar protein synthetic rate was calculated to be 0.82 g day-1 kg-1 body weight, and the mean turnover rate was 1.47%/day of total muscle myofibrillar protein. 4. The estimations of myofibrillar protein turnover rate derived from the two methods are compared and the differences discussed.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 750147     DOI: 10.1042/cs0540471

Source DB:  PubMed          Journal:  Clin Sci Mol Med        ISSN: 0301-0538


  3 in total

1.  Endogenous 3-methylhistidine excretion in healthy women and men with reference to muscle protein metabolism.

Authors:  M Neuhäuser; K H Bässler
Journal:  Z Ernahrungswiss       Date:  1984-09

2.  Whole-body protein breakdown and 3-methylhistidine excretion during brief fasting, starvation, and intravenous repletion in man.

Authors:  S F Lowry; G D Horowitz; M Jeevanandam; A Legaspi; M F Brennan
Journal:  Ann Surg       Date:  1985-07       Impact factor: 12.969

3.  3-Methylhistidine excretion as an index of myofibrillar protein catabolism in neuromuscular disease.

Authors:  R O McKeran; D Halliday; P Purkiss; P Royston
Journal:  J Neurol Neurosurg Psychiatry       Date:  1979-06       Impact factor: 10.154

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.